Zinc involvement in opioid addiction and analgesia - should zinc supplementation be recommended for opioid-treated persons?

Substance Abuse: Treatment, Prevention, and Policy

Volumn 10, Issue 1, 2015, Pages

  Ciubotariu, Diana ^a   Ghiciuc, Cristina Mihaela ^a   Lupuşoru, Că tă lina Elena ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Addiction; Analgesia; Opioid dependence; Zinc

Indexed keywords

OPIATE PEPTIDE; OPIATE RECEPTOR; ZINC;

ANALGESIA; ANIMAL; BRAIN; DRUG EFFECTS; HUMAN; LIVER; METABOLISM; OPIATE ADDICTION; PATHOPHYSIOLOGY; WITHDRAWAL SYNDROME;

ANALGESIA; ANIMALS; BRAIN; HUMANS; LIVER; OPIOID PEPTIDES; OPIOID-RELATED DISORDERS; RECEPTORS, OPIOID; SUBSTANCE WITHDRAWAL SYNDROME; ZINC;

EID: 84938598299     PISSN: None     EISSN: 1747597X     Source Type: Journal    
DOI: 10.1186/s13011-015-0025-2     Document Type: Article

References (110)

1. Fraga CG. Relevance, essentiality and toxicity of trace elements in human health. Mol Aspects Med. 2005;26:235-44.
2. McCall KA, Huang C, Fierke CA. Function and mechanism of zinc metalloenzymes. J Nutr. 2000;130:S1437-46.
3. Osredkar J, Sustar N. Copper and Zinc, Biological Role and Significance of Copper/Zinc Imbalance. J Clinic Toxicol. 2011;S:3:1-18.
4. Laity JH, Lee BM, Wright PE. Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol. 2001;11:39-46.
5. Bitanihirwe BK, Cunningham MG. Zinc: the brain's dark horse. Synapse. 2009;63:1029-49. doi: 10.1002/syn.20683 .
6. Xie X, Smart TG. Modulation of long-term potentiation in rat hippocampal pyramidal neurons by zinc. Pflugers Arch. 1994;427:481-86.
7. Lu YM, Taverna FA, Tu R, Ackerley CA, Wang YT, Roder J. Endogenous Zn(2+) is required for the induction of long-term potentiation at rat hippocampal mossy fiber-CA3 synapses. Synapse. 2000;38:187-97.
8. Grabrucker AM. A role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders. Dev Neurobiol. 2014;74:136-46. doi: 10.1002/dneu.22089 . Epub 2013 Sep 11.
9. Jan HH, Chen IT, Tsai YY, Chang YC. Structural role of zinc ions bound to postsynaptic densities. J Neurochem. 2002;83:525-34.
10. Grabrucker AM, Knight MJ, Proepper C, Bockmann J, Joubert M, Rowan M, et al. Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J. 2011;30:569-81. doi: 10.1038/emboj.2010.336 . Epub 2011 Jan 7.
11. Gulya K, Kovács GL, Kása P. Partial depletion of endogenous zinc level by (D-Pen2, D-Pen5)enkephalin in the rat brain. Life Sci. 1991;48:PL57-62.
12. Frederickson CJ, Bush AI. Synaptically released zinc: physiological functions and pathological effects. Biometals. 2001;14:353-66.
13. Sawashita J, Takeda A, Okada S. Change of zinc distribution in rat brain with increasing age. Brain Res Dev Brain Res. 1997;102:295-8.
14. Qian J, Noebels JL. Visualization of transmitter release with zinc fluorescence detection at the mouse hippocampal mossy fibre synapse. J Physiol. 2005;566:747-58.
15. Vogt K, Mellor J, Tong G, Nicoll R. The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron. 2000;26:187-96.
16. Wessells KR, Brown KH. Estimating the global prevalence of zinc deficiency: results based on zinc availability in national food supplies and the prevalence of stunting. PLoS One. 2012;7:e50568. doi: 10.1371/journal.pone.0050568 . Epub 2012 Nov 29.
17. Caulfield LE, Zavaleta N, Shankar AH, Merialdi M. Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival. Am J Clin Nutr. 1998;68:499S-508S.
18. Fischer Walker CL, Ezzati M, Black RE. Global and regional child mortality and burden of disease attributable to zinc deficiency. Eur J Clin Nutr. 2009;63:591-97. doi: 10.1038/ejcn.2008.9 . Epub 2008 Feb 13.
19. King JC. Zinc: an essential but elusive nutrient1,2,3. Am J Clin Nutr. 2011;94:679S-84S.
20. Moran VH, Stammers AL, Medina MW, Patel S, Dykes F, Souverein OW, et al. The relationship between zinc intake and serum/plasma zinc concentration in children: a systematic review and dose-response meta-analysis. Nutrients. 2012;4:841-58.
21. Livingstone C. Zinc: Physiology, Deficiency, and Parenteral Nutrition. Nutr Clin Pract. 2015;30(3):371-82.
22. Bonaventura P, Benedetti G, Albarède F, Miossec P. Zinc and its role in immunity and inflammation. Autoimmun Rev. 2014, doi: 10.1016/j.autrev.2014.11.008 .
23. Wong CP, Rinaldi NA, Ho E. Zinc deficiency enhanced inflammatory response by increasing immune cell activation and inducing IL6 promoter demethylation. Mol Nutr Food Res. 2015, doi: 10.1002/mnfr.201400761
24. Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem. 2004;15:572-78.
25. Hagmeyer S, Haderspeck JC, Grabrucker AM. Behavioral impairments in animal models for zinc deficiency. Front Behav Neurosci. 2015;8:443. doi: 10.3389/fnbeh.2014.00443 .
26. Prasad AS. Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr. 2013;4:176-90.
27. Pfaender S, Grabrucker AM. Characterization of biometal profiles in neurological disorders. Metallomics. 2014;6:960-77.
28. Chowanadisai W, Kelleher SL, Lönnerdal B. Zinc deficiency is associated with increased brain zinc import and LIV-1 expression and decreased ZnT-1 expression in neonatal rats. J Nutr. 2005;135:1002-7.
29. Takeda A, Tamano H. Insight into zinc signaling from dietary zinc deficiency. Brain Res Rev. 2009;62:33-44. doi: 10.1016/j.brainresrev.2009.09.003 .
30. Sandstead HH. Subclinical zinc deficiency impairs human brain function. J Trace Elem Med Biol. 2012;26:70-3. doi: 10.1016/j.jtemb.2012.04.018 .
31. Taneja SK, Mandal R, Girhotra S. Long term excessive Zn-supplementation promotes metabolic syndrome-X in Wistar rats fed sucrose and fat rich semisynthetic diet. Indian J Exp Biol. 2006;44:705-18.
32. Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51:225-7.
33. Salzman MB, Smith EM, Koo CJ. Excessive oral zinc supplementation. Pediatr Hematol Oncol. 2002;24:582-4.
34. Cuajungco MP, Lees GJ. Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol Dis. 1997;4:137-69.
35. Watt NT, Whitehouse IJ, Hooper NM. The role of zinc in Alzheimer's disease. Int J Alzheimers Dis. 2010;2011:971021. doi: 10.4061/2011/971021 .
36. Forte G, Alimonti A, Violante N, Di Gregorio M, Senofonte O, Petrucci F, et al. Calcium, copper, iron, magnesium, silicon and zinc content of hair in Parkinson's disease. J Trace Elem Med Biol. 2005;19:195-201.
37. Pals P, Van Everbroeck B, Grubben B, Viaene MK, Dom R, van der Linden C, et al. Case-control study of environmental risk factors for Parkinson's disease in Belgium. Eur J Epidemiol. 2003;18:1133-42.
38. Zhao HW, Lin J, Wang XB, Cheng X, Wang JY, Hu BL, et al. Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson's disease. PLoS One. 2013;8:e83060. doi: 10.1371/journal.pone.0083060.eCollection 2013.
39. Tarohda T, Ishida Y, Kawai K, Yamamoto M, Amano R. Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats. Anal Bioanal Chem. 2005;383:224-34.
40. Larson AA, Kovács KJ, Spartz AK. Intrathecal Zn2+ attenuates morphine antinociception and the development of acute tolerance. Eur J Pharmacol. 2000;407:267-72.
41. Ciubotariu D, Nechifor M. Zinc involvements in the brain. Rev Med Chir Soc Med Nat Iasi. 2007;111:981-5.
42. Tejwani GA, Hanissian SH. Modulation of mu, delta and kappa opioid receptors in rat brain by metal ions and histidine. Neuropharmacology. 1990;29:445-52.
43. Ogawa N, Mizuno S, Fukushima M, Mori A. Effects of guanine nucleotides, transition metals and temperature on enkephalin receptors of rat brain membranes. Peptides. 1985;6 Suppl 1:23-8.
44. Sadlik J, Pach J, Winnik L, Piekoszewski W. Concentration of zinc, copper and magnesium in the serum of drug addicts. Przegl Lek. 2000;57:563-4.
45. Elnimr T, Hashem A, Assar R. Heroin dependence effects on some major and trace elements. Biol Trace Elem Res. 1996;54:153-62.
46. Ruiz Martínez M, Gil Extremera B, Maldonado Martín A, Cantero-Hinojosa J, Moreno-Abadía V. Trace elements in drug addicts. Klin Wochenschr. 1990;68:507-11.
47. Potkin SG, Shore D, Torrey EF, Weinberger DR, Gillin JC, Henkin RI, et al. Cerebrospinal fluid zinc concentrations in ex-heroin addicts and patients with schizophrenia: some preliminary observations. Biol Psychiatry. 1982;17:1315-22.
48. Larson AA, Kitto KF. Manipulations of zinc in the spinal cord, by intrathecal injection of zinc chloride, disodium-calcium-EDTA, or dipicolinic acid, alter nociceptive activity in mice. J Pharmacol Exp Ther. 1997;282:1319-25.
49. Larson AA, Kitto KF. Chelation of zinc in the extracellular area of the spinal cord, using ethylenediaminetetraacetic acid disodium-calcium salt or dipicolinic acid, inhibits the antinociceptive effect of capsaicin in adult mice. J Pharmacol Exp Ther. 1999;288:759-65.
50. Liu T, Walker JS, Tracey DJ. Zinc alleviates thermal hyperalgesia due to partial nerve injury. Neuroreport. 1999;10:645-9.
51. Matsunami M, Kirishi S, Okui T, Kawabata A. Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels. Neuroscience. 2011;181:257-64. doi: 10.1016/j.neuroscience.2011.02.044 .
52. Nozaki C, Vergnano AM, Filliol D, Ouagazzal AM, Le Goff A, Carvalho S, et al. Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit. Nat Neurosci. 2011;14:1017-22. doi: 10.1038/nn.2844 .
53. Tamba BI, Leon MM, Petreus T. Common trace elements alleviate pain in an experimental mouse model. J Neurosci Res. 2013;91:554-61. doi: 10.1002/jnr.23191 .
54. Kesmati M, Torabi M. Interaction between Analgesic Effect of Nano and Conventional size of Zinc Oxide and Opioidergic System Activity in Animal Model of Acute Pain. Basic Clin Neurosci. 2014;5:80-7.
55. Freisinger E, Vašák M. Cadmium in metallothioneins. Met Ions Life Sci. 2013;11:339-71. doi: 10.1007/978-94-007-5179-8_11 .
56. McClain CJ, Su LC. Zinc deficiency in the alcoholic: a review. Alcohol Clin Exp Res. 1983;7:5-10.
57. Valberg LS, Flanagan PR, Ghent CN, Chamberlain MJ. Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis. Dig Dis Sci. 1985;30:329-33.
58. Dinsmore W, Callender ME, McMaster D, Todd SJ, Love AH. Zinc absorption in alcoholics using zinc-65. Digestion. 1985;32:238-42.
59. Zarski JP, Arnaud J, Dumolard L, Favier A, Rachail M. Trace elements (zinc, copper, manganese) in alcoholic cirrhosis: effect of chronic alcoholism. Gastroenterol Clin Biol. 1985;9:664-9.
60. Giroux E, Schechter PJ, Schoun J, Sjoerdsma A. Reduced binding of added zinc in serum of patients with decompensated hepatic cirrhosis. Eur J Clin Invest. 1977;7:71-3.
61. Mills PR, Fell GS, Bessent RG, Nelson LM, Russell RI. A study of zinc metabolism in alcoholic cirrhosis. Clin Sci (Lond). 1983;64:527-35.
62. Arnaud J, Touvier M, Galan P, Andriollo-Sanchez M, Ruffieux D, Roussel AM, et al. Determinants of serum zinc concentrations in a population of French middle-age subjects (SU.VI.MAX cohort). Eur J Clin Nutr. 2010;64:1057-64.
63. Schuhmacher M, Domingo JL, Corbella J. Zinc and copper levels in serum and urine: relationship to biological, habitual and environmental factors. Sci Total Environ. 1994;148:67-72.
64. Szyszko M, Czarnowski W. Smoking influence on cadmium, lead, selenium and zinc level in placenta, cord blood and maternal blood of women at delivery from Gdansk region. Przegl Lek. 2006;63:993-7.
65. Unkiewicz-Winiarczyk A, Bagniuk A, Gromysz-Kałkowska K, Szubartowska E. Calcium, magnesium, iron, zinc and copper concentration in the hair of tobacco smokers. Biol Trace Elem Res. 2009;128:152-60.
66. Infante F, Domínguez E, Trujillo D, Luna A. Metal contamination in illicit samples of heroin. J Forensic Sci. 1999;44:110-3.
67. Bora T, Merdivan M, Hamamci C. Levels of trace and major elements in illicit heroin. J Forensic Sci. 2002;47:959-63.
68. Chan KW, Tan GH, Wong RC. Investigation of trace inorganic elements in street doses of heroin. Sci Justice. 2013;53:73-80. doi: 10.1016/j.scijus.2012.08.004 .
69. Iyengar V, Chou PP, Costantino AG, Cook CB. Excessive urinary excretion of zinc in drug addicts: a preliminary study during methadone detoxification. J Trace Elem Electrolytes Health Dis. 1994;8:213-5.
70. Santolaria-Fernández FJ, Gómez-Sirvent JL, González-Reimers CE, Batista-López JN, Jorge-Hernández JA, Rodríguez-Moreno F, et al. Nutritional assessment of drug addicts. Drug Alcohol Depend. 1995;38:11-8.
71. Saeland M, Haugen M, Eriksen FL, Smehaugen A, Wandel M, Böhmer T, et al. Living as a drug addict in Oslo, Norway--a study focusing on nutrition and health. Public Health Nutr. 2009;12:630-6. doi: 10.1017/S1368980008002553 .
72. Essatara MB, Morley JE, Levine AS, Elson MK, Shafer RB, McClain CJ. The role of the endogenous opiates in zinc deficiency anorexia. Physiol Behav. 1984;32:475-8.
73. Qiu J, Zhang C, Borgquist A, Nestor CC, Smith AW, Bosch MA, et al. Insulin excites anorexigenic proopiomelanocortin neurons via activation of canonical transient receptor potential channels. Cell Metab. 2014;19:682-93. doi: 10.1016/j.cmet.2014.03.004 .
74. Angelova MG, Petkova-Marinova TV, Pogorielov MV, Loboda AN, Nedkova-Kolarova VN, Bozhinova AN. Trace Element Status (Iron, Zinc, Copper, Chromium, Cobalt, and Nickel) in Iron-Deficiency Anaemia of Children under 3 Years. Anemia. 2014;2014:718089. doi: 10.1155/2014/718089 .
75. Hidalgo J, Giralt M, Garvey JS, Armario A. Effect of morphine administration on rat liver metallothionein and zinc metabolism. J Pharmacol Exp Ther. 1991;259:274-478.
76. Floriańczyk B. Zinc level in selected tissues of ethanol and morphine intoxicated mice. Med Sci Monit. 2000;6:680-3.
77. Fowler CB, Pogozheva ID, LeVine 3rd H, Mosberg HI. Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites. Biochemistry. 2004;43:8700-10.
78. Stengaard-Pedersen K. Inhibition of enkephalin binding to opiate receptors by zinc ions: possible physiological importance in the brain. Acta Pharmacol Toxicol (Copenh). 1982;50:213-20.
79. Sindreu C, Storm DR. Modulation of neuronal signal transduction and memory formation by synaptic zinc. Front Behav Neurosci. 2011;5:68. doi: 10.3389/fnbeh.2011.00068 .
80. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE. The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator. Science (New York, NY). 2009;323:934-7. doi: 10.1126/science.1166127 .
81. Wu HE, Hong JS, Tseng LF. Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse. Eur J Pharmacol. 2007;571:145-51. doi: 10.1016/j.ejphar.2007.06.012 .
82. Connor MA, Chavkin C. Ionic zinc may function as an endogenous ligand for the haloperidol-sensitive sigma 2 receptor in rat brain. Mol Pharmacol. 1992;42:471-9.
83. Rodríguez-Muñoz M, Sánchez-Blázquez P, Herrero-Labrador R, Martínez-Murillo R, Merlos M, Vela JM, et al. The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control. Antioxid Redox Signal. 2015;22:799-818. doi: 10.1089/ars.2014.5993 .
84. Hanissian SH, Tejwani GA. Histidine abolishes the inhibition by zinc of naloxone binding to opioid receptors in rat brain. Neuropharmacology. 1988;27:1145-9.
85. Fregoneze JB, Luz CP, Castro L, Oliveira P, Lima AK, Souza F, et al. Zinc and water intake in rats: investigation of adrenergic and opiatergic central mechanisms. Braz J Med Biol Res. 1999;32:1217-22.
86. Yoshida H, Tsuji K, Sakata T, Nakagawa A, Morita S. Clinical study of tongue pain: Serum zinc, vitamin B12, folic acid, and copper concentrations, and systemic disease. Br J Oral Maxillofac Surg. 2010;48:469-72. doi: 10.1016/j.bjoms.2009.08.001 .
87. Durusoy C, Ozenli Y, Adiguzel A, Budakoglu IY, Tugal O, Arikan S, et al. The role of psychological factors and serum zinc, folate and vitamin B12 levels in the aetiology of trichodynia: a case-control study. Clin Exp Dermatol. 2009;34:789-92. doi: 10.1111/j.1365-2230.2008.03165.x .
88. Kashefi F, Khajehei M, Tabatabaeichehr M, Alavinia M, Asili J. Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: a placebo-controlled randomized trial. Pain Manag Nurs. 2014;15:826-33. doi: 10.1016/j.pmn.2013.09.001 .
89. Kugelmas M. Preliminary observation: oral zinc sulfate replacement is effective in treating muscle cramps in cirrhotic patients. J Am Coll Nutr. 2000;19:13-5.
90. Lombardo F, Fiducia M, Lunghi R, Marchetti L, Palumbo A, Rizzo F, et al. Effects of a dietary supplement on chronic pelvic pain syndrome (Category IIIA), leucocytospermia and semen parameters. Andrologia. 2012;44 Suppl 1:672-8. doi: 10.1111/j.1439-0272.2011.01248.x .
91. Vormann J, Worlitschek M, Goedecke T, Silver B. Supplementation with alkaline minerals reduces symptoms in patients with chronic low back pain. J Trace Elem Med Biol. 2001;15:179-83.
92. Temiye EO, Duke ES, Owolabi MA, Renner JK. Relationship between Painful Crisis and Serum Zinc Level in Children with Sickle Cell Anaemia. Anemia. 2011, 698586. doi: 10.1155/2011/698586
93. Prasad AS, Cossack ZT. Zinc supplementation and growth in sickle cell disease. Ann Intern Med. 1984;100:367-71.
94. Prasad AS: Zinc is an antioxidant and anti-inflammatory agent: Its role in human. Frontiers in Nutrition 2014;1:14 doi: 10.3389/fnut.2014.00014.
95. Ciubotariu D, Pascu Baican M, Nechifor M, Tartau L. P.1.c.010 Zinc does not affect morphine analgesia in morphine-dependent rats. European Neurospsychopharmacology. 2012, 22, Supplement 2:S172.
96. Gromov LA, Serdiuk EA. The analgesic activity of coordination compounds of methionine enkephalin with divalent metals. Farmakol Toksikol. 1990;53:24-5.
97. Dursun N, Erenmemisoglu A, Suer C, Gogusten B. The effect of zinc deficiency on morphine antinociception. Res Commun Alcohol Subst Abuse. 1995;16:47-52. doi: 19174,35400005190799 .
98. Alexa T, Marza A, Voloseniuc T, Tamba B. Enhanced analgesic effects of tramadol and common trace element coadministration in mice. Neurosci Res. 2015. doi: 10.1002/jnr.23609
99. Lynch WJ, Nicholson KL, Dance ME, Morgan RW, Foley PL. Animal Models of Substance Abuse and Addiction: Implications for Science, Animal Welfare, and Society. Comparative Med. 2010;60:177-88.
100. Kieffer BL, Gavériaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol. 2002;66:285-306.
101. Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain. 2007;11:490-518.
102. Leppert W. The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilities. Contemp Oncol (Pozn). 2012;16:125-31.
103. Kolarzyk E, Chrostek Maj J, Pach D, Janik A, Kwiatkowski J, Szurkowska M. Assessment of daily nutrition ratios of opiate-dependent persons before and after 4 years of methadone maintenance treatment. Przegl Lek. 2005;62:368-72.
104. Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A. Cancer cachexia-pathophysiology and management. J Gastroenterol. 2013;48:574-94.
105. Zanocchi M, Maero B, Nicola E, Martinelli E, Luppino A, Gonella M, et al. Chronic pain in a sample of nursing home residents: prevalence, characteristics, influence on quality of life (QoL). Arch Gerontol Geriatr. 2008;47:121-8.
106. Katz RL, Keen CL, Litt IF, Hurley LS, Kellams-Harrison KM, Glader LJ. Zinc deficiency in anorexia nervosa. J Adolesc Health Care. 1987;8:400-6.
107. Dhawan DK, Chadha VD. Zinc: a promising agent in dietary chemoprevention of cancer. Indian J Med Res. 2010;132:676-82.
108. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97-129.
109. Gavériaux-Ruff C. Opiate-induced analgesia: contributions from mu, delta and kappa opioid receptors mouse mutants. Curr Pharm Des. 2013;19:7373-81.
110. Ahmad AH, Ismail Z. c-fos and its Consequences in Pain. Malays J Med Sci. 2002;9:3-8.